Desjardins Global Asset Management Inc. Has $57,000 Holdings in DocuSign, Inc. (NASDAQ:DOCU)

Desjardins Global Asset Management Inc. raised its position in DocuSign, Inc. (NASDAQ:DOCUFree Report) by 60.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 966 shares of the company’s stock after buying an additional 364 shares during the period. Desjardins Global Asset Management Inc.’s holdings in DocuSign were worth $57,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in DocuSign by 2.4% in the third quarter. Vanguard Group Inc. now owns 20,982,387 shares of the company’s stock valued at $881,260,000 after buying an additional 482,472 shares in the last quarter. Capital World Investors lifted its position in shares of DocuSign by 128.3% during the first quarter. Capital World Investors now owns 5,683,838 shares of the company’s stock worth $608,853,000 after purchasing an additional 3,193,727 shares in the last quarter. Morgan Stanley lifted its position in shares of DocuSign by 1.7% during the third quarter. Morgan Stanley now owns 3,219,450 shares of the company’s stock worth $135,217,000 after purchasing an additional 53,553 shares in the last quarter. Clearbridge Investments LLC lifted its position in shares of DocuSign by 1.9% during the first quarter. Clearbridge Investments LLC now owns 3,186,783 shares of the company’s stock worth $341,368,000 after purchasing an additional 58,555 shares in the last quarter. Finally, Renaissance Technologies LLC lifted its position in shares of DocuSign by 0.3% during the first quarter. Renaissance Technologies LLC now owns 2,872,900 shares of the company’s stock worth $167,490,000 after purchasing an additional 8,300 shares in the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.

DocuSign Price Performance

Shares of NASDAQ DOCU opened at $55.70 on Friday. DocuSign, Inc. has a fifty-two week low of $38.11 and a fifty-two week high of $64.76. The firm has a market capitalization of $11.44 billion, a P/E ratio of 154.73, a P/E/G ratio of 5.08 and a beta of 0.89. The company’s 50 day simple moving average is $55.90 and its 200 day simple moving average is $52.12.

DocuSign (NASDAQ:DOCUGet Free Report) last issued its earnings results on Thursday, March 7th. The company reported $0.15 EPS for the quarter, beating the consensus estimate of $0.09 by $0.06. DocuSign had a net margin of 2.68% and a return on equity of 13.91%. The firm had revenue of $712.39 million during the quarter, compared to the consensus estimate of $698.05 million. Sell-side analysts expect that DocuSign, Inc. will post 0.86 EPS for the current fiscal year.

Insider Buying and Selling at DocuSign

In other DocuSign news, CEO Allan C. Thygesen sold 7,680 shares of the company’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $61.27, for a total value of $470,553.60. Following the completion of the sale, the chief executive officer now owns 111,767 shares of the company’s stock, valued at $6,847,964.09. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director Teresa Briggs sold 499 shares of the stock in a transaction on Thursday, February 29th. The shares were sold at an average price of $52.99, for a total transaction of $26,442.01. Following the completion of the sale, the director now owns 6,169 shares of the company’s stock, valued at $326,895.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Allan C. Thygesen sold 7,680 shares of the stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $61.27, for a total transaction of $470,553.60. Following the sale, the chief executive officer now directly owns 111,767 shares of the company’s stock, valued at approximately $6,847,964.09. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 54,871 shares of company stock valued at $3,176,199. Corporate insiders own 17.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on DOCU shares. Morgan Stanley upgraded shares of DocuSign from an “underweight” rating to an “equal weight” rating and upped their target price for the stock from $49.00 to $64.00 in a research report on Tuesday, January 16th. Royal Bank of Canada reiterated a “sector perform” rating and set a $59.00 target price on shares of DocuSign in a research report on Friday, April 12th. Wells Fargo & Company reduced their target price on shares of DocuSign from $55.00 to $45.00 and set an “underweight” rating on the stock in a research report on Monday, February 5th. UBS Group upgraded shares of DocuSign from a “sell” rating to a “neutral” rating and upped their target price for the stock from $48.00 to $62.00 in a research report on Friday, April 12th. Finally, JMP Securities restated a “market outperform” rating and issued a $84.00 price objective on shares of DocuSign in a report on Friday, April 12th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, DocuSign currently has an average rating of “Hold” and an average price target of $60.25.

Check Out Our Latest Analysis on DocuSign

About DocuSign

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Featured Stories

Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCUFree Report).

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.